100 Participants NeededMy employer runs this trial

CoCo Chatbot for Informed Consent

FM
Overseen ByFunda Meric-Bernstam, MD
Age: 18+
Sex: Any
Trial Phase: Academic
Sponsor: M.D. Anderson Cancer Center
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

What You Need to Know Before You Apply

What is the purpose of this trial?

The purpose of this study is to determine the feasibility of implementing the chatbot "CoCo" in the IC process for research studies. We hypothesize that implementing a chatbot into the IC process will facilitate accurate information delivery and enhance participant comprehension and process satisfaction compared to traditional remote consent methods.

Who Is on the Research Team?

FM

Funda Meric-Bernstam, MD

Principal Investigator

UT MD Anderson

Are You a Good Fit for This Trial?

This trial is for adults (18 or older) who speak English and are being considered for participation in certain clinical research studies. They must be able to understand and agree to give informed consent.

Inclusion Criteria

I understand the study and am willing to give my consent to participate.
Patients who are being considered for enrollment in selected clinical research studies
I am 18 years old or older.
See 1 more

Timeline for a Trial Participant

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Remote Informed Consent

Participants engage with the chatbot 'CoCo' for the informed consent process

1-2 weeks

Feasibility Assessment

Evaluation of the feasibility of the chatbot-facilitated remote informed consent process

6 months

Follow-up

Participants are monitored for safety and adverse events

1 year

What Are the Treatments Tested in This Trial?

Interventions

  • CoCo Chatbot

Trial Overview

The study is testing whether using the CoCo chatbot can improve how information about a research study is explained during the consent process, compared to traditional remote methods.

How Is the Trial Designed?

1

Treatment groups

Experimental Treatment

Group I: Phase I Feasibility Cohort: Remote IC Process for Non-Therapeutic StudiesExperimental Treatment1 Intervention

Find a Clinic Near You

Who Is Running the Clinical Trial?

M.D. Anderson Cancer Center

Lead Sponsor

Trials
3,107
Recruited
1,813,000+